CCA
NARI

Conestoga Capital Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Conestoga Capital Advisors’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-16,150
Closed -$782K – 148
2020
Q2 		$782K Buy
+16,150
New +$771K 0.02% 103

Other funds holding NARI

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Conestoga Capital Advisors's NARI Position: Q3 2020 in Review

Conestoga Capital Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q3 2020, closing a stake of 16,150 shares — an estimated $782K sold.

Conestoga Capital Advisors first reported a position in NARI in Q2 2020 and held it in 1 quarter. The position peaked at $782K in Q2 2020. 99 funds tracked by Wall St. Rank hold NARI as of Q3 2020.

  • Conestoga Capital Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Conestoga Capital Advisors sold 16,150 Inari Medical, Inc. Common Stock shares in Q3 2020, an estimated $782K.
  • Conestoga Capital Advisors first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Conestoga Capital Advisors's Inari Medical, Inc. Common Stock position peaked at $782K in Q2 2020.
  • 99 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2020.

Based on Conestoga Capital Advisors's 13F filing for Q3 2020, filed 23 Oct 2020.